Ctrl Worx Watch List › Company

Guided Therapeutics Inc (GTHP): material weakness open at least 2,128 days

By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.

Guided Therapeutics Inc reported ineffective internal control over financial reporting because of a material weakness in 6 filings since Apr 7, 2021. It stated one or more material weaknesses in 16 more SEC filings that gave no conclusion on whether that control is effective. The latest was its 10-Q for the period ended Jun 30, 2026.

Checked against SEC EDGAR: Oct 29, 2026 · Entry #10221

Causes the company named

Accounting expertise and resources · 22Entity-level and governance · 11Complex or non-routine accounting · 8Inventory · 6

Insufficient accounting expertise and inadequate Board/Audit Committee oversight of complex transactions.

What the latest filing says

Based on that evaluation, the Chief Executive Officer/Acting Chief Financial Officer has concluded that our disclosure controls and procedures were ineffective as of June 30, 2026, due to the existence of material weaknesses in our internal control over financial reporting. The material weaknesses identified arose from a lack of recourses to properly research and account for complex transactions and lack of oversight and approval by the Board of Directors and Audit Committee, including formally documented approval of significant transactions, including related party transactions. While management is currently in the early stages of developing a remediation plan, we have yet to fully remediate this material weakness. Changes in Internal Control Over Financial Reporting There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. 45 Table of Co [...]

From the controls section of the 10-Q filed Aug 13, 2026. Read the full filing on SEC EDGAR.

Company response: Guided Therapeutics Inc can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.

Filings

Follow GTHP for free

Get an email when Guided Therapeutics Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.

Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Guided Therapeutics Inc or the SEC. Not investment advice. Why you can rely on the Watch List.